According to Rongtai Health's announcement, on October 30, 2020, the company publicly issued 6 million A-share convertible bonds and raised 600 million yuan in capital. The net amount after deducting expenses was 594 million yuan. In 2025, the company changed the use of some convertible bonds to raise capital and postponed the project. On December 25, the company and its subsidiaries Shanghai Altay Robotics, Shanghai Moxin Intelligent Technology, Shanghai Xingzhuo Intelligent Technology signed a “Tripartite Supervision Agreement” with the sponsor agency Wanhe Securities and the Agricultural Bank of China Shanghai Yangtze River Delta Integrated Demonstration Zone Branch. The subsidiary has set up a special account to raise capital. As of December 24, the balance of each special account was 0 yuan.

According to Rongtai Health's announcement, on October 30, 2020, the company publicly issued 6 million A-share convertible bonds and raised 600 million yuan in capital. The net amount after deducting expenses was 594 million yuan. In 2025, the company changed the use of some convertible bonds to raise capital and postponed the project. On December 25, the company and its subsidiaries Shanghai Altay Robotics, Shanghai Moxin Intelligent Technology, Shanghai Xingzhuo Intelligent Technology signed a “Tripartite Supervision Agreement” with the sponsor agency Wanhe Securities and the Agricultural Bank of China Shanghai Yangtze River Delta Integrated Demonstration Zone Branch. The subsidiary has set up a special account to raise capital. As of December 24, the balance of each special account was 0 yuan.